Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)		Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance (in Shares)
Balance at Feb. 11, 2020
Balance (in Shares) at Feb. 11, 2020
Issuance of Founder Shares to Sponsor	[1]	$ 575	24,425		25,000
Issuance of Founder Shares to Sponsor (in Shares)	[1]	5,750,000
Issuance of Representative Shares		$ 20	800		820
Issuance of Representative Shares (in Shares)		200,000
Net loss				(1,000)	(1,000)
Balance at Mar. 31, 2020		$ 595	25,225	(1,000)	24,820
Balance (in Shares)
Balance at Feb. 11, 2020
Balance (in Shares) at Feb. 11, 2020
Net loss					(102,977)
Balance at Sep. 30, 2020		$ 696	5,102,284	(102,977)	5,000,003
Balance (in Shares)
Balance (in Shares)		5,950,000
Balance at Mar. 31, 2020		$ 595	25,225	(1,000)	24,820
Balance (in Shares) at Mar. 31, 2020		5,950,000
Net loss
Balance at Jun. 30, 2020		$ 595	25,225	(1,000)	24,820
Balance (in Shares)		5,950,000
Balance (in Shares)		5,950,000
Balance (in Shares) at Jun. 30, 2020		5,950,000
Net loss				(101,977)	(101,977)
Balance at Sep. 30, 2020		$ 696	5,102,284	$ (102,977)	5,000,003
Balance (in Shares)		5,950,000
Sale of 22,977,568 Units, net of underwriting discounts		$ 2,298	224,656,352		224,658,650
Sale of 22,977,568 Units, net of underwriting discounts (in Shares)		22,977,568
Sale of 594,551 Private Units		$ 60	5,945,450		5,945,510
Sale of 594,551 Private Units (in Shares)		594,551
Forfeiture of Founder Shares		$ (1)	1
Forfeiture of Founder Shares (in Shares)		(5,608)
Common stock subject to possible redemption		$ (2,256)	$ (225,524,744)		$ (225,527,000)
Common stock subject to possible redemption (in Shares)		(22,552,700)
Balance (in Shares)		6,963,811

[1] Includes 750,000 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).